More than 14,000 urological specialists and affiliated medical professionals are expected to stream into Copenhagen in March 2018 for Europe’s biggest urological event.

Hosting the 33rd Annual European Association of Urology (EAU) Congress is evidence of both the Danish capital’s leading medical research and its capacity and skill in hosting large-scale events. The event is expected to attract more than 1,400 expert speakers and lecturers to the Bella Center over five days for an in-depth scientific programme. The congress aims to assess clinical practices and key research developments through state-of-the art lectures, HD video surgery sessions, skill-boosting hands-on training and practice-oriented courses.

Greater Copenhagen’s life sciences industry is world-leading for R&D spending, clinical testing and drug development. Denmark is number two in the world for developing biotechnology and number one in Europe in number of clinical trials per capita, owing to a strong life science industry employing more than 40,000 people.

Its Medicon Valley knowledge hub is home to leading researchers, clinicians and academics; 4 life science universities with 50,000 students; 22 hospitals of which 11 are university hospitals, and more than 150 biotech companies and 200 medtech companies.

Key urology research centres include the Department of Urology at Rigshospitalet and the Urology Research Unit at Herlev Hospital – both of which held on-site teaching events during the last EAU Congress held in Copenhagen in 1984. Therapeutic strongholds in the region include cancer, including R&D in urologic cancers including cancers of the prostate, bladder, kidney and testicles.


(via EAU18, Copenhagen Capacity)